VALERIE PENDERS: Open Payments
NPI 1326540840 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 22 payments from 10 companies in 2025. Trend: 2023 $190 · 2024 $478 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $403 |
| Alnylam Pharmaceuticals Inc. | 3 | $171 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| PFIZER INC. | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Amgen Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: Attruby, AMVUTTRA, LEQVIO, VYNDAQEL, JARDIANCE, REPATHA, ELIQUIS, ONPATTRO.
Industry payments across PA — which companies pay providers there.
